| Date |
Report No. |
Title |
| Date Dec. 14, 1999 |
Report No. HEHS-00-34 |
Title
United States General Accounting Office GAO
December 1999 Report to the Ranking Minority Member, Committee on Veterans’ Affairs, U.S. Senate VA HEALTH CARE VA’s Management of Drugs on Its National Formulary GAO/HEHS-00-34 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-283993 December 14, 1999 The Honorable John D. Rockefeller... |
| Date Nov. 30, 1999 |
Report No. AIMD-00-17 |
Title
United States General Accounting Office GAO
November 1999 Report to the Attorney General SEIZED DRUGS AND WEAPONS DEA Needs to Improve Certain Physical Safeguards and Strengthen Accountability GAO/AIMD-00-17 Contents Letter Appendixes
Appendix I: Scope and Methodology 3 28 31 8 Appendix II: Comments From the Drug Enforcement Administration Tables Table 1: Seized Drug Activity for the Year Ended Se... |
| Date Nov. 29, 1999 |
Report No. NSIAD-00-27 |
Title
United States General Accounting Office GAO
November 1999 Report to the Chairman, Committee on Armed Services, House of Representatives DEFENSE INVENTORY Inadequate Compliance With Controls for Excess Firearms and Other Sensitive Items GAO/NSIAD-00-27 Contents Letter Appendixes
Appendix I: Appendix II: Scope and Methodology Comments From the Department of Defense 3 16 18 20 10 Appendix III: GAO Co... |
| Date Sept. 28, 1999 |
Report No. T-HEHS-99-198 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Tuesday, September 28, 1999 Testimony
Before the Subcommittee on Health and Environment, Committee on Commerce, House of Representatives MEDICARE Beneficiaries’ Prescription Drug Coverage
Statement of Laura A. Dummit, Associate Director Health Financing and Public Health Issues Health, Education, and Human... |
| Date Aug. 26, 1999 |
Report No. NSIAD/OSI-99-133 |
Title
United States General Accounting Office GAO
August 1999 Report to the Secretary of Defense, the Attorney General, and the Secretary of the Treasury DEPARTMENT OF DEFENSE Military Assistance Provided at Branch Davidian Incident GAO/NSIAD/OSI-99-133 United States General Accounting Office Washington, D.C. 20548 National Security and International Affairs Division B-276428 Letter August 26, 1999 The ... |
| Date July 20, 1999 |
Report No. T-HEHS-99-171 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 2:30 p.m. Tuesday, July 20, 1999 Testimony
Before the Special Committee on Aging, U.S. Senate PRESCRIPTION DRUG BENEFITS Impact of Medicare HMOs’ Use of Formularies on Beneficiaries
Statement of William J. Scanlon, Director Health Financing and Public Health Issues Health, Education, and Human Services Division GAO/T... |
| Date July 20, 1999 |
Report No. HEHS-99-166 |
Title
United States General Accounting Office GAO
July 1999 Report to Congressional Requesters PRESCRIPTION DRUG BENEFITS Implications for Beneficiaries of Medicare HMO Use of Formularies GAO/HEHS-99-166 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-279239 July 20, 1999 The Honorable Charles E. Grassley Chairman The Honorable John B. ... |
| Date June 23, 1999 |
Report No. T-HEHS-99-153 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Wednesday, June 23, 1999 Testimony
Before the Committee on Finance, U.S. Senate MEDICARE Considerations for Adding a Prescription Drug Benefit
Statement of Laura A. Dummit, Associate Director Health Financing and Public Health Issues Health, Education, and Human Services Division GAO/T-HEHS-99-153 Medicare: ... |
| Date June 8, 1999 |
Report No. HEHS-99-134R |
Title
GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-282860 June 8, 1999 The Honorable Don Nickles United States Senate Subject: Defense Health Care: Pharmacy Copavments Dear Senator Nickles: This responds to your March 17, 1999, referral to us of a letter that several constituents sent you regarding our recent report and testimony on ... |
| Date June 1, 1999 |
Report No. HEHS-99-98 |
Title
United States General Accounting Office GAO
June 1999 Report to the Chairman and Ranking Minority Member, Committee on Armed Services, U.S. Senate PRESCRIBING PSYCHOLOGISTS DOD Demonstration Participants Perform Well but Have Little Effect on Readiness or Costs GAO/HEHS-99-98 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-280869 ... |
| Date April 28, 1999 |
Report No. HEHS/NSIAD/RCED-99-132 |
Title
United States General Accounting Office GAO
April 1999 Report to Congressional Requesters ANTIMICROBIAL RESISTANCE Data to Assess Public Health Threat From Resistant Bacteria Are Limited GAO/HEHS/NSIAD/RCED-99-132 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-281564 April 28, 1999 The Honorable Edward M. Kennedy Ranking Minority... |
| Date April 28, 1999 |
Report No. RCED-99-74 |
Title
United States General Accounting Office GAO
April 1999 Report to the Honorable Tom Harkin, Ranking Minority Member, Committee on Agriculture, Nutrition, and Forestry, U.S. Senate FOOD SAFETY The Agricultural Use of Antibiotics and Its Implications for Human Health GAO/RCED-99-74 GAO United States General Accounting Office Washington, D.C. 20548 Resources, Community, and Economic Development Divisi... |
| Date March 10, 1999 |
Report No. T-HEHS-99-75 |
Title
GAO
For Release on Delivery Expected at 1:00 p.m. EST Wednesday, March 10, 1999 United States General Accounting Office Testimony Before the Subcommittee on Military Personnel, Committee on Armed Services, House of Representatives DEFENSE HEALTH CARE Need for Top-to-Bottom Redesign of Pharmacy Programs
Statement of Stephen P. Backhus, Director Veterans Affairs and Military Health Care Issues Hea... |
| Date Dec. 4, 1998 |
Report No. HEHS-99-6 |
Title
United States General Accounting Office GAO
December 1998 Report to Congressional Requesters SPECIALTY CARE Heart Attack Survivors Treated by Cardiologists More Likely to Take Recommended Drugs GAO/HEHS-99-6 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-276534 December 4, 1998 The Honorable Ben Nighthorse Campbell The Honorable ... |
| Date Nov. 16, 1998 |
Report No. HEHS-99-16R |
Title
GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-279966 November 16, 1998 The Honorable William M. Thomas Chairman, Subcommittee on Health Committee on Ways and Means House of Representatives The Honorable Philip M. Crane House of Representatives Subject: Medicare: Coverage of Pumas Used to Administer Intravenous Drugs Medicare’ ... |
| Date June 12, 1998 |
Report No. HEHS-98-176 |
Title
United States General Accounting Office GAO
June 1998 Report to Congressional Committees DEFENSE HEALTH CARE Fully Integrated Pharmacy System Would Improve Service and Cost-Effectiveness GAO/HEHS-98-176 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-277613 June 12, 1998 The Honorable Dirk Kempthorne Chairman The Honorable Max Cle... |
| Date March 17, 1998 |
Report No. HEHS-98-21 |
Title
United States General Accounting Office GAO
March 1998 Report to the Chairman, Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives FOOD AND DRUG ADMINISTRATION Improvements Needed in the Foreign Drug Inspection Program GAO/HEHS-98-21 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-275814 M... |
| Date July 10, 1997 |
Report No. T-HEHS-97-171 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 9:30 a.m. Thursday, July 10, 1997 Testimony
Before the Subcommittee on Health, Committee on Veterans’ Affairs, House of Representatives FEDERAL DRUG PRICES Effects of Opening the Pharmaceutical Schedule Are Uncertain
Statement of Bernice Steinhardt, Director Health Services Quality and Public Health Issues Health, Ed... |
| Date June 20, 1997 |
Report No. HEHS-97-134 |
Title
United States General Accounting Office GAO
June 1997 Report to the Chairman and Ranking Minority Member, Subcommittee on Military Personnel, Committee on National Security, House of Representatives MILITARY RETIREES’ HEALTH CARE Costs and Other Implications of Options to Enhance Older Retirees’ Benefits GAO/HEHS-97-134 GAO United States General Accounting Office Washington, D.C. 20548 Health,... |
| Date June 11, 1997 |
Report No. HEHS-97-60 |
Title
United States General Accounting Office GAO
June 1997 Report to Congressional Committees and the Administrator of General Services DRUG PRICES Effects of Opening Federal Supply Schedule for Pharmaceuticals Are Uncertain GAO/HEHS-97-60 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-276585 June 11, 1997 The Honorable Fred Thompson,... |
| Date April 1, 1997 |
Report No. HEHS-97-83 |
Title
United States General Accounting Office GAO
April 1997 Report to the Chairmen and Ranking Minority Members, Committee on Armed Services, U.S. Senate, and Committee on National Security, House of Representatives DEFENSE HEALTH CARE Need for More Prescribing Psychologists Is Not Adequately Justified GAO/HEHS-97-83 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, ... |
| Date Feb. 27, 1997 |
Report No. T-HEHS-97-84 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 1:00 p.m. Thursday, February 27, 1997 Testimony
Before the Subcommittee on Military Personnel, Committee on National Security, House of Representatives DEFENSE HEALTH CARE Limits to Older Retirees’ Access to Care and Proposals for Change
Statement of Stephen P. Backhus, Director Veterans’ Affairs and Military Healt... |
| Date Feb. 27, 1997 |
Report No. NSIAD-97-75 |
Title
United States General Accounting Office GAO
February 1997 Report to the Chairman, Subcommittee on National Security, International Affairs, and Criminal Justice, Committee on Government Reform and Oversight, House of Representatives DRUG CONTROL Long-Standing Problems Hinder U.S. International Efforts GAO/NSIAD-97-75 GAO United States General Accounting Office Washington, D.C. 20548 National Secur... |
| Date Feb. 21, 1997 |
Report No. HEHS-97-47 |
Title
United States General Accounting Office GAO
February 1997 Report to Congressional Requesters PHARMACY BENEFIT MANAGERS FEHBP Plans Satisfied With Savings and Services, but Retail Pharmacies Have Concerns GAO/HEHS-97-47 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-276005 February 21, 1997 Congressional Requesters The Office of P... |
| Date Oct. 11, 1996 |
Report No. HEHS-97-22R |
Title
GAO UnitedStates GeneralAccountingOffke Washington,D.C.20648 Health,E&~tionandHnmanServicesDivlsion B-274728 October 11, 1996 Stark The Honorable Fortney H. (Pete) Ranking Minority Member Subcommittee on Health Committee on Ways and Means House of Representatives Dear Mr. Stark: In 1995, Medicare part B allowance& for drugs, nutrients, and nutrient-related supplies totaled over $2.2 billion. For o... |
| Date Oct. 11, 1996 |
Report No. HEHS-97-15 |
Title
United States General Accounting Office GAO
October 1996 Report to the Chairman, Subcommittee on Hospitals and Health Care, Committee on Veterans’ Affairs, House of Representatives VA HEALTH CARE Opportunities to Significantly Reduce Outpatient Pharmacy Costs G A O years
1921 - 1996 GAO/HEHS-97-15 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Ser... |
| Date Sept. 19, 1996 |
Report No. T-HEHS-96-216 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Thursday, September 19, 1996 Testimony
Before the Subcommittee on Oversight and Investigations Committee on Commerce, House of Representatives PRESCRIPTION DRUG PRICING Implications for Retail Pharmacies
Statement of Sarah F. Jaggar, Director Health Services Quality and Public Health Health, Education, and H... |
| Date Sept. 12, 1996 |
Report No. T-HEHS-96-212 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. September 12, 1996 Testimony
Before the Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Reform and Oversight, U. S. House of Representatives PRESCRIPTION DRUGS Implications of Drug Labeling and Off-Label Use
Statement of Sarah F. Jagger Director of Health Services Qua... |
| Date Sept. 5, 1996 |
Report No. T-HEHS-96-206 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 9:30 a.m. Thursday, September 5, 1996 Testimony
Before the Subcommittee on Civil Service Committee on Government Reform and Oversight House of Representatives BLUE CROSS AND BLUE SHIELD Change in Pharmacy Benefits Affects Federal Enrollees
Statement of Sarah F. Jaggar, Director Health Services Quality and Public Health... |
| Date July 19, 1996 |
Report No. HEHS-96-182R |
Title
GAO united states General Accounting Offke Washixujton, D.C. 20648 Health, Education and Human Services Division B-272648 July 19, 1996 The Honorable William Cohen Chairman, Subcommittee on Oversight of Government Management and the District of Columbia Committee on Governmental Affairs United States Senate The Honorable David Pryor Ranking Minority Member Subcommittee on Post Office and Civil Ser... |
| Date June 11, 1996 |
Report No. AIMD-96-72 |
Title
United States General Accounting Office GAO
June 1996 Report to Congressional Requesters PRESCRIPTION DRUGS AND MEDICAID Automated Review Systems Can Help Promote Safety, Save Money G A O years
1921 - 1996 GAO/AIMD-96-72 GAO United States General Accounting Office Washington, D.C. 20548 Accounting and Information Management Division B-261530 June 11, 1996 The Honorable William F. Clinger, Jr. Chai... |
| Date June 11, 1996 |
Report No. T-HEHS-96-162 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Tuesday, June 11, 1996 Testimony
Before the Subcommittee on Hospitals and Health Care, Committee on Veterans’ Affairs, House of Representatives VA HEALTH CARE Opportunities to Reduce Outpatient Pharmacy Costs
Statement of David P. Baine, Director, Health Care Delivery and Quality Issues Health, Education, ... |
| Date May 14, 1996 |
Report No. PEMD-96-7 |
Title
United States General Accounting Office GAO
May 1996 Report to the Ranking Minority Member, Committee on Science, House of Representatives CHOLESTEROL TREATMENT A Review of the Clinical Trials Evidence G A O years
1921 - 1996 GAO/PEMD-96-7 GAO United States General Accounting Office Washington, D.C. 20548 Program Evaluation and Methodology Division B-266080 May 14, 1996 The Honorable George E. Bro... |
| Date May 2, 1996 |
Report No. T-PEMD-96-9 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. EST Thursday May 2, 1996 Testimony
Before the Subcommittee on Health and Environment, Committee on Commerce, House of Representatives FDA REVIEW TIMES Statement of Mary R. Hamilton, Ph.D. Director of Program Evaluation in Human Services Areas Program Evaluation and Methodology Division G A O years
1921 - 199... |
| Date May 1, 1996 |
Report No. HEHS-96-139W |
Title
United States General Accounting Office GAO
May 1996 Health, Education, and Human Services Division Reports Health Education Employment Social Security Welfare Veterans GAO/HEHS-96-139W Preface This monthly bibliography lists the U.S. General Accounting Office’s (GAO) recently released products on health, education, employment, social security, disability, welfare, and veterans issues. To learn ... |
| Date April 23, 1996 |
Report No. PEMD-96-8R |
Title
- - United Statea General Accounting Offlce Washington, D.C. 20646 Program Evaluation and Methodology Division B-271814 April 23, 1996 The Honorable Thomas J. Bliley Chairman Committee on Commerce House of Representatives Dear Mr. Chairman: The Food and Drug Administration (FDA) is responsible for ensuring the safety of biologics, human drugs, medical devices.,. food additives, and animal drugs an... |
| Date April 5, 1996 |
Report No. HEHS-96-71 |
Title
United States General Accounting Office GAO
April 1996 Report to the Chairman, Committee on Labor and Human Resources, U.S. Senate EUROPEAN UNION DRUG APPROVAL Overview of New European Medicines Evaluation Agency and Approval Process G A O years
1921 - 1996 GAO/HEHS-96-71 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-261605 Apri... |
| Date March 28, 1996 |
Report No. T-HEHS-96-114 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 9:30 a.m. Thursday, March 28, 1996 Testimony
Before the Special Committee on Aging, U.S. Senate PRESCRIPTION DRUGS AND THE ELDERLY Many Still Receive Potentially Harmful Drugs Despite Recent Improvements
Statement of Sarah F. Jaggar, Director Health Financing and Public Health Issues Health, Education, and Human Servic... |
| Date Feb. 21, 1996 |
Report No. T-PEMD-96-6 |
Title
United States General Accounting Office Testimony
Before the Committee on Labor and Human Resources U.S. Senate For Release on Delivery Expected at 9~30a.m. EST Wednesday February 2 1,1996 Statement of Mary R. Hamilton, Ph.D. Director of Program Evaluation in the Human Services Area Program Evaluation and Methodology Division GAOfI’ -PEMD-96-6 Dear Madam Chairman: In October 1995, GAO issued a r... |
| Date Feb. 7, 1996 |
Report No. T-HEHS-96-85 |
Title
United States General Accounting Office GAO
For Releaseon Delivery Expectedat 1:00p.m. Wednesday February7.19% Testimony
Before the Committeeon Insurance California StateSenate PHARMACY BENEFIT MANAGERS Early Results on Ventures With Drug Manufacturers
Statementof John C. Hansen,AssistantDirector Health Financing and Public Health Issues Health, Education, and Human ServicesDivision Mr. Chairman a... |
| Date Dec. 21, 1995 |
Report No. HEHS-96-60R |
Title
GAO United States General Accounting Office Washington, D.C. 20548 Health, Education and Human Services Division B-266229 December 21, 1995 The Honorable Nancy Landon Kassebaum Chairman, Committee on Labor and Human Resources United States Senate Dear Madam Chairman: Under current law, U.S. pharmaceutical manufacturers must obtain approval from the Food and Drug Administration (FDA) to export drug... |
| Date Dec. 8, 1995 |
Report No. HEHS-96-53R |
Title
B-259939 December 8, 1995 The Iionorable Nancy L. Kassebaurn Chairman, Corrmittee on Labor and Human Resources United States Senate Dear Madam Chairman: The Congress, industry groups, and others have raised concerns about delays in the Food and Drug Administration's (FDA) approval of new medical device, pharmaceutical, and biologic products. In the last 5 years, the Congress provided additional fu... |
| Date Nov. 9, 1995 |
Report No. HEHS-96-45 |
Title
United States General Accounting Office GAO
November 1995 Report to the Honorable Ron Wyden, House of Representatives PHARMACY BENEFIT MANAGERS Early Results on Ventures With Drug Manufacturers GAO/HEHS-96-45 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-257388 November 9, 1995 The Honorable Ron Wyden House of Representatives De... |
| Date Oct. 20, 1995 |
Report No. PEMD-96-1 |
Title
United States General Accounting Office GAO
October 1995 Report to Congressional Requesters FDA DRUG APPROVAL Review Time Has Decreased in Recent Years GAO/PEMD-96-1 GAO United States General Accounting Office Washington, D.C. 20548 Program Evaluation and Methodology Division B-266023 October 20, 1995 The Honorable Nancy Landon Kassebaum Chairman The Honorable Edward M. Kennedy Ranking Minority Me... |
| Date Sept. 13, 1995 |
Report No. HEHS-95-141 |
Title
United States General Accounting Office GAO
September 1995 Report to the Chairman and Ranking Minority Member, Human Resources and Intergovernmental Relations Subcommittee, House Committee on Government Reform and Oversight CANCER DRUG RESEARCH Contrary to Allegation, NIH Hydrazine Sulfate Studies Were Not Flawed GAO/HEHS-95-141 GAO United States General Accounting Office Washington, D.C. 20548 He... |
| Date Aug. 24, 1995 |
Report No. PEMD-95-12 |
Title
United States General Accounting Office GAO
August 1995 Report to the Ranking Minority Member, Committee on Commerce, House of Representatives NONPRESCRIPTION DRUGS Value of a PharmacistControlled Class Has Yet to Be Demonstrated GAO/PEMD-95-12 GAO United States General Accounting Office Washington, D.C. 20548 Program Evaluation and Methodology Division B-252141 August 24, 1995 The Honorable John ... |
| Date July 24, 1995 |
Report No. HEHS-95-152 |
Title
United States General Accounting Office GAO
July 1995 Report to the Honorable Ron Wyden, House of Representatives PRESCRIPTION DRUGS AND THE ELDERLY Many Still Receive Potentially Harmful Drugs Despite Recent Improvements GAO/HEHS-95-152 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-259603 July 24, 1995 The Honorable Ron Wyden H... |
| Date July 1, 1995 |
Report No. AA-95-18(3) |
Title
United States General Accounting Office GAO Health, Education and Human Services Division July 1995 J 1National and Public A Health Issues Issue Area Active Assignments GAO/AA-95-18(3) / ItHo Foreword This report was prepared primarily to inform Congressional members and key staff of ongoing assignments in the General Accounting Office's National and Public Health Issues issue area This report con... |
| Date April 28, 1995 |
Report No. HEHS-95-90 |
Title
United States General Accounting Office 3AO Report to the Chairman, Special Committee on Aging, U.S. Senate Apil 1995 PRESCRIPTION DRUG
PRICES Official Index Overstates Producer Price Inflation GAO/IEHS-95-90 GAO ~~~~~~Washington,D.C. 20548 United States General Accounting Office Health, Education, and Human Services Division B-260293 April 28, 1995 The Honorable William S. Cohen Chairman, Special... |
| Date Jan. 18, 1995 |
Report No. GGD-95-52R |
Title
GAO United States General Accounting Offke Washington, D.C. 20548 General Government Division B-259550 January 18, 1995 Jr. The Honorable F. James Sensenbrenner, House of Representatives Dear Mr. Sensenbrenner: This correspondence responds to your request for information on how certain controlled substances are regulated, particularly methylphenidate-a central nervous system stimulant approved for... |
